Signaling Pathways
-
A8633 Concanamycin A1 CitationTarget: Vacuolar-type ATPaseSummary: V-type (vacuolar) H+-ATPase inhibitor
-
A8634 WEHI-539 hydrochloride1 CitationSummary: Bcl-xL inhibitor,high affinity and selective
-
A8637 IOWH-032Target: CFTRSummary: CFTR inhibitor
-
A8641 LEE011Target: Cyclin-Dependent KinasesSummary: CDK4/6 inhibitor
-
A8642 R5472 CitationTarget: Cyclin-Dependent KinasesSummary: CDK1/2/4 inhibitor,ATP-competitive
-
A8647 CapecitabineSummary: DNA, RNA and protein synthesis inhibitor
-
A8649 NU 7026Target: PI3K|DNA-PK|ATMSummary: DNPK inhibitor,ATP-competitive and potent
-
A8650 SaxagliptinTarget: DPP-4Summary: Selective DPP4 inhibitor
-
A8660 Cilengitide1 CitationTarget: IntegrinsSummary: Integrin inhibitor for αvβ3 and αvβ5
-
A8669 AC 55541Target: PARSummary: PAR2 agonist,potent and selective